Literature DB >> 1594351

Cognitive-behavioral pain management in children with juvenile rheumatoid arthritis.

G A Walco1, J W Varni, N T Ilowite.   

Abstract

Decreasing chronic joint pain is a major goal in the management of juvenile rheumatoid arthritis. Cognitive-behavioral self-regulatory techniques were taught to children with juvenile rheumatoid arthritis to reduce musculoskeletal pain intensity and to facilitate better adaptive functioning. Subjects were 13 children between the ages of 4.5 and 16.9 years who had pauciarticular or systemic onset juvenile rheumatoid arthritis. Baseline data included an initial comprehensive assessment of pain, disease activity, and level of functional disability, as well as pain intensity ratings gathered over a 4-week period. Subjects were seen for eight individual sessions in which self-regulatory techniques (progressive muscle relaxation, guided imagery, meditative breathing) were taught, and parents were seen for two sessions in which key aspects of behavioral pain management techniques were reviewed. Results indicated that these techniques led to substantial reduction of pain intensity, which generalized to outside the clinic setting. Six- and 12-month follow-up data showed consistent decreases in pain as well as improved adaptive functioning. The data suggest that cognitive-behavioral interventions for pain are an effective adjunct to standard pharmacologic interventions for pain in patients with juvenile rheumatoid arthritis.

Entities:  

Mesh:

Year:  1992        PMID: 1594351

Source DB:  PubMed          Journal:  Pediatrics        ISSN: 0031-4005            Impact factor:   7.124


  15 in total

Review 1.  How painful is juvenile chronic arthritis?

Authors:  W Kuis; C J Heijnen; J A Hogeweg; G Sinnema; P J Helders
Journal:  Arch Dis Child       Date:  1997-11       Impact factor: 3.791

2.  Self-reported pain and disease symptoms persist in juvenile idiopathic arthritis despite treatment advances: an electronic diary study.

Authors:  Maggie H Bromberg; Mark Connelly; Kelly K Anthony; Karen M Gil; Laura E Schanberg
Journal:  Arthritis Rheumatol       Date:  2014-02       Impact factor: 10.995

3.  Cognitive coping skills training in children with sickle cell disease pain.

Authors:  K M Gil; J J Wilson; J L Edens; E Workman; J Ready; J Sedway; R Redding-Lallinger; C W Daeschner
Journal:  Int J Behav Med       Date:  1997

4.  Disease self-management needs of adolescents with cancer: perspectives of adolescents with cancer and their parents and healthcare providers.

Authors:  J N Stinson; L Sung; A Gupta; M E White; L A Jibb; E Dettmer; N Baker
Journal:  J Cancer Surviv       Date:  2012-04-28       Impact factor: 4.442

5.  Effects of perceived stress on pediatric chronic pain.

Authors:  J W Varni; M A Rapoff; S A Waldron; R A Gragg; B H Bernstein; C B Lindsley
Journal:  J Behav Med       Date:  1996-12

6.  The Role of Salivary Neuropeptides in Pediatrics: Potential Biomarkers for Integrated Therapies.

Authors:  Lynn A Gershan; Paul L Durham; Jaci Skidmore; Joshua Shimizu; Ryan J Cady; Xiaoming Sheng; Christopher G Maloney
Journal:  Eur J Integr Med       Date:  2015-08       Impact factor: 1.314

Review 7.  Assessment and management of pain in juvenile idiopathic arthritis.

Authors:  Jennifer N Stinson; Nadia J C Luca; Lindsay A Jibb
Journal:  Pain Res Manag       Date:  2012 Nov-Dec       Impact factor: 3.037

8.  [Juvenile fibromyalgia syndrome].

Authors:  H Michels; K Gerhold; R Häfner; W Häuser; A Illhardt; K Mönkemöller; M Richter; L Schuchmann
Journal:  Schmerz       Date:  2008-06       Impact factor: 1.107

9.  Parental risk and resistance factors among children with juvenile rheumatic disease: a four-year predictive study.

Authors:  C Timko; M Baumgartner; R H Moos; J J Miller
Journal:  J Behav Med       Date:  1993-12

Review 10.  Nonpharmacological treatment of pain in rheumatic diseases and other musculoskeletal pain conditions.

Authors:  Natoshia Raishevich Cunningham; Susmita Kashikar-Zuck
Journal:  Curr Rheumatol Rep       Date:  2013-02       Impact factor: 4.592

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.